3 ms·
It's a highly formalized clinical trial, it would be nonsensical to misrepresent or exaggerate the results. The preliminary analysis is based on 94 cases; not a
by svara 6y ago
It's a highly formalized clinical trial, it would be nonsensical to misrepresent or exaggerate the results. The preliminary analysis is based on 94 cases; not a huge number, but totally reasonable to draw conclusions from.
- sergioisidoro 6y agoMy point was the validation and peer-review. There are many possible confounding factors, including isolation and mask use. Also I might have misread the protocol, since I'm no medical scientist, but wasn't the efficacy of the vaccine measured only in a 1 month timespan? Are we even sure the effects are long lasting? I just don't want to get the hopes too high too soon. The crash after a positivity high can be quite bad. Reuters is even live streaming Wall Street because of this announcement!